/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
EUR/USD
-1.07%
Natural Gas
-2.67%
Gold
-2.58%
BTC
-0.86%
ETH
+0.51%
SPX
-1.03%
VIX
-2.14%
Economic Calendar
EUR/USD
-1.07%
Natural Gas
-2.67%
Gold
-2.58%
BTC
-0.86%
ETH
+0.51%
SPX
-1.03%
VIX
-2.14%
Economic Calendar
BTC
-0.86%
ETH
+0.51%
XRP
-0.56%
ADA
-0.73%
SOL
-0.21%
Review
Review
Review
ASEAN chair Indonesia to intensify talks on code for South China Sea
11 minutes ago
Germany has evidence of war crimes in Ukraine ‘in three-digit range’ – prosecutor
41 minutes ago
Tesla’s Elon Musk found not liable in trial over 2018 ‘funding secured’ tweets
about 1 hour ago
Russia’s war on Ukraine latest: Zelenskiy vows to defend ‘fortress’ Bakhmut
about 2 hours ago
China says political trust with Russia has deepened after envoy’s visit
about 3 hours ago
U.S. judge denies FTC request to stop Meta from acquiring VR firm Within
about 3 hours ago
BTC Fear & Greed Index Stays Greedy Despite a Bearish BTC
about 3 hours ago
If You Did Not Hear This Coming, You Had Better Get Your Ears Checked
about 7 hours ago
Deepening Bearish Sentiment in Natural Gas Takes it to New Lows
about 11 hours ago
S&P 500’s Rally to $4300+ Is Still on Track
about 11 hours ago
NASDAQ, S&P 500, Dow Jones Analysis – Stocks Retreat As Treasury Yields Rally
about 11 hours ago
S&P 500 Weekly Price Forecast – Stock Markets Continue to Look Higher
about 12 hours ago
Quick Links
:
Forecasts
Economic Calendar
Crypto
Commodities
FXTM Academy
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
NTLA
profile
Intellia Therapeutics Inc
Follow
NTLA
(
Nasdaq - US
)
Closed
43.21
-1.39 (-3.12%)
in
:
usd
•
As of: Feb 03, 2023 15:59
UTC -5
Open
43.05
High
44.45
Low
42.42
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Intellia Therapeutics Inc
CEO
John M. Leonard
Headquarters
40 erie street, suite 130
cambridge, ma 02139, united states
Auditor
Deloitte & Touche LLP
Employees
485
Share Holders
12
Website
www.intelliatx.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company is pursuing two primary approaches to fully realize the transformative potential of CRISPR/Cas9 in vivo programs that use intravenously administered CRISPR as the therapy and ex vivo programs that use CRISPR to create the therapy by using engineered human cells.?
Intellia Therapeutics Inc
Statistics
Valuation Measures
Market Capitalization
2
3.40B
Enterprise Value
3.26B
Enterprise Value/EBITDA
(ttm)
-7.74
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
3.98
Price to Sales
(ttm)
66.05
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
100.00%
Operating Margin
(ttm)
-859.92%
Profit Margin
(ttm)
-877.10%
Return on Equity
(ttm)
-47.79%
Return on Invested Capital
(ttm)
-48.37%
Return on Assets
(ttm)
-37.68%
Income Statement
Revenue
(ttm)
51.40M
Revenue Per Share
(ttm)
0.65
Gross Profit
(ttm)
51.40M
EBITDA
(ttm)
3
-421.07M
Net Income Avi to Common
(ttm)
-442.02M
Diluted EPS
(ttm)
-5.87
Share Statistics
Beta (5Y Monthly)
1.90
52-Week Change
-54.97%
S&P500 52-Week Change
-8.09%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
78.68M
Dividend Yield
0.00%
Float
4
75.61M
%
Held by Insiders
3.90%
%
Held by Institutions
85.61%
Balance Sheet
Total Cash
(mrq)
828.19M
Total Cash Per Share
(mrq)
10.53
Total Debt
(mrq)
0.00
Total Debt/Equity
(mrq)
0.00%
Current Ratio
(mrq)
6.55%
Quick Ratio
(mrq)
6.55%
Book Value Per Share
(mrq)
10.77
Cash Flow
Operating Cash Flow Per Share
(ytd)
-3.20
Free Cash Flow
(ytd)
-252.91M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker